https://n.neurology.org/content/96/8/e1251#:~:text=A%20recent%20meta%2Danalysis%20of,of%201.2%2F100%2C000%2Fy.
you should read this study from Wales, it is another data point which estimates the incidence at 7.8 and prevalence at 75. As far as I understand it, this is very different from Invex's stated numbers, which work on an incidence * 4.3 years to determine prevalence. Whereas, this data from wales would show prevalence = 7.8 * 9.6 years, over double the amount of time with the disease. Could be due to climate or something in Wales, im not sure, but it isn't solely due to obesity
DCF Valuation Model for Invex Therapeutics, page-79
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable